rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1990-9-4
|
pubmed:abstractText |
Long-term effects of bezafibrate on in vivo production of VLDL-triglyceride were studied in the rat. Bezafibrate given at a daily dose of 30 mg/kg body weight for 14 days produced a decrease not only in triglyceride by 51% but in cholesterol by 28% and phospholipid by 18%. Despite a marked reduction in plasma triglyceride concentrations, there was no significant change in the rate of VLDL-triglyceride secretion from the liver into the circulation between bezafibrate-treated and control animals (1113 +/- 58 and 1234 +/- 63 micrograms/min, respectively). In addition, bezafibrate produced no change in lipid composition in VLDL. These results suggest that bezafibrate enhances triglyceride removal from the circulation, which leads to reduction in plasma triglyceride.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bezafibrate,
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Detergents,
http://linkedlifedata.com/resource/pubmed/chemical/Insulin,
http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, VLDL,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/tyloxapol,
http://linkedlifedata.com/resource/pubmed/chemical/very low density lipoprotein...
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0168-8227
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
163-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2198155-Animals,
pubmed-meshheading:2198155-Bezafibrate,
pubmed-meshheading:2198155-Blood Glucose,
pubmed-meshheading:2198155-Cholesterol,
pubmed-meshheading:2198155-Cholesterol, HDL,
pubmed-meshheading:2198155-Detergents,
pubmed-meshheading:2198155-Insulin,
pubmed-meshheading:2198155-Lipoproteins, VLDL,
pubmed-meshheading:2198155-Liver,
pubmed-meshheading:2198155-Male,
pubmed-meshheading:2198155-Phospholipids,
pubmed-meshheading:2198155-Polyethylene Glycols,
pubmed-meshheading:2198155-Rats,
pubmed-meshheading:2198155-Rats, Inbred Strains,
pubmed-meshheading:2198155-Reference Values,
pubmed-meshheading:2198155-Triglycerides
|
pubmed:articleTitle |
Long-term effects of bezafibrate on in vivo VLDL-triglyceride production in the rat.
|
pubmed:affiliation |
Department of Medicine, Hyogo Medical Center for Adults, Akashi, Japan.
|
pubmed:publicationType |
Journal Article
|